Hetero Sued for Valsartan Contamination

Drug Industry Daily
A A
A federal lawsuit filed in Massachusetts claims Indian generic drugmaker Hetero and its U.S. subsidiary Camber Pharmaceuticals ignored warning signs that the blood-pressure drug valsartan was contaminated and continued to supply it in the United States.

To View This Article:

Login

Subscribe To Drug Industry Daily